Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/8443
Title: Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis
Authors: Vosse, D.
Landewe, R.
Garnero, P.
VAN DER HEIJDE, Desiree 
van der Linden, S
GEUSENS, Piet 
Issue Date: 2008
Publisher: OXFORD UNIV PRESS
Source: RHEUMATOLOGY, 47(8). p. 1219-1222
Abstract: Objective. There is a lack of knowledge on factors that reliably can predict radiological changes in patients with AS. We have investigated whether urinary C-terminal cross-linking telopeptide of type I (CTX-I) and type II (CTX-II) collagen, as specific biochemical markers of bone and cartilage degradation, respectively, are associated with radiological damage and progression, and with BMD in patients with AS. Methods. Eighty-three patients with AS [mean (s.d.) age: 50.4 (12) yrs, 65 male, mean (s.d.) disease duration after diagnosis: 16.7 (10) yrs] who participate in an ongoing cohort study of patients with AS [Outcome in AS International Study (OASIS) cohort] were assessed for urinary CTX-I and -II. Results of both biochemical markers were compared with baseline scores for radiological damage (modified modified Stoke Ankylosing Spondylitis Spine Score, primarily reflecting syndesmophyte-formation and -growth), and with scores for radiological progression after 2 yrs follow-up. Markers were also associated with disease activity parameters and BMD. Results. Mean duration of complaints was 28.6 yrs. At that time, 54% of patients had signs of radiological damage, and 35% of them showed radiological progression after 2 yrs. Baseline radiological damage (rho = 0.24; P <= 0.05) correlated with CTX-II, but not with CTX-I. CTX-II correlated with serological markers of inflammation (ESR rho = 0.29 and CRP rho = 0.30; P <= 0.01), but not with baseline BASDAI or BMD. There was a negative correlation between CTX-I and BMD of the trochanter (rho =-0.31; P <= 0.01) In multivariate analyses, CTX-II significantly and independently contributed to explaining variation in radiological damage (standardized beta = 0.27; P = 0.03) and progression (standardized beta = 0.27; P = 0.05). Conclusion. In AS, cartilage degradation plays a role in explaining radiological-damage and - progression in the spine.
Notes: Univ Hosp Maastricht, Div Rheumatol, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands. Univ Maastricht, CAPHRI Res Inst, Maastricht, Netherlands. INSERM, Res Unit 664, F-69008 Lyon, France. Synarc, Mol Markers, Lyon, France. Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands. Univ Hasselt, Biomed Res Inst, Hasselt, Belgium.
Keywords: ankylosing spondylitis; biochemical markers; bone degradation; cartilage degradation; radiological damage; radiological progression
Document URI: http://hdl.handle.net/1942/8443
ISSN: 1462-0324
e-ISSN: 1462-0332
DOI: 10.1093/rheumatology/ken148
ISI #: 000257787200020
Category: A1
Type: Journal Contribution
Validations: ecoom 2009
Appears in Collections:Research publications

Show full item record

SCOPUSTM   
Citations

43
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

46
checked on Mar 26, 2024

Page view(s)

70
checked on Jul 28, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.